(주)엔지켐생명과학

{
  "address": "충북 제천시",
  "ceo_name": "손기영",
  "certificate": [
    {
      "cert_number": "20001522710601",
      "changes": "",
      "disclosure_date": "2000-05-29",
      "first_cert_date": "2000-05-29",
      "no": "1",
      "type": "연구개발기업",
      "valid_period": "2000-05-29 ~ 2002-05-28"
    },
    {
      "cert_number": "20021522211498",
      "changes": "",
      "disclosure_date": "2002-11-15",
      "first_cert_date": "2000-05-29",
      "no": "2",
      "type": "신기술기업(고도기술수반산업)",
      "valid_period": "2002-11-15 ~ 2004-11-14"
    },
    {
      "cert_number": "041522032400228",
      "changes": "",
      "disclosure_date": "2004-11-29",
      "first_cert_date": "2000-05-29",
      "no": "3",
      "type": "신기술기업(고도기술수반산업)",
      "valid_period": "2004-11-29 ~ 2006-11-14"
    },
    {
      "cert_number": "20060100369",
      "changes": "",
      "disclosure_date": "2006-11-02",
      "first_cert_date": "2000-05-29",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2006-11-15 ~ 2008-11-14"
    },
    {
      "cert_number": "20110300133",
      "changes": "",
      "disclosure_date": "2011-07-07",
      "first_cert_date": "2000-05-29",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2011-07-07 ~ 2013-07-06"
    },
    {
      "cert_number": "20130300179",
      "changes": "",
      "disclosure_date": "2013-07-18",
      "first_cert_date": "2000-05-29",
      "no": "6",
      "type": "벤처투자유형",
      "valid_period": "2013-07-07 ~ 2015-07-06"
    },
    {
      "cert_number": "20150300245",
      "changes": "",
      "disclosure_date": "2015-06-25",
      "first_cert_date": "2000-05-29",
      "no": "7",
      "type": "벤처투자유형",
      "valid_period": "2015-07-07 ~ 2017-07-06"
    },
    {
      "cert_number": "20170107256",
      "changes": "",
      "disclosure_date": "2017-06-22",
      "first_cert_date": "2000-05-29",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2017-07-07 ~ 2019-07-06"
    },
    {
      "cert_number": "20190108425",
      "changes": "",
      "disclosure_date": "2019-07-19",
      "first_cert_date": "2000-05-29",
      "no": "9",
      "type": "연구개발유형",
      "valid_period": "2019-07-07 ~ 2021-07-06"
    },
    {
      "cert_number": "20210729020060",
      "changes": "",
      "disclosure_date": "2021-07-29",
      "first_cert_date": "2000-05-29",
      "no": "10",
      "type": "연구개발유형",
      "valid_period": "2021-07-07 ~ 2024-07-06"
    },
    {
      "cert_number": "20240702020008",
      "changes": "",
      "disclosure_date": "2024-07-02",
      "first_cert_date": "2000-05-29",
      "no": "11",
      "type": "연구개발유형",
      "valid_period": "2024-07-07 ~ 2027-07-06"
    }
  ],
  "company_name": "(주)엔지켐생명과학",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 42413781000,
      "cost_of_sales": 24221315000,
      "current_assets": 219238512000,
      "current_liabilities": 42188783000,
      "gross_profit": 2416316000,
      "net_income": -25419445000,
      "net_income_bs": -24918899000,
      "non_current_assets": 27599042000,
      "non_current_liabilities": 3213022000,
      "non_operating_expenses": 15122854000,
      "non_operating_income": 4202211000,
      "operating_profit": -14498802000,
      "revenue": 26637631000,
      "sga_expenses": 16915118000,
      "total_assets": 246837553000,
      "total_equity": 201435749000,
      "total_liabilities": 45401805000
    },
    "2023": {
      "capital_stock": 42532781000,
      "cost_of_sales": 31514528000,
      "current_assets": 168443075000,
      "current_liabilities": 11072933000,
      "gross_profit": 3597432000,
      "net_income": -9068827000,
      "net_income_bs": -8781125000,
      "non_current_assets": 36815041000,
      "non_current_liabilities": 405278000,
      "non_operating_expenses": 734727000,
      "non_operating_income": 5614156000,
      "operating_profit": -13948256000,
      "revenue": 35111961000,
      "sga_expenses": 17545688000,
      "total_assets": 205258117000,
      "total_equity": 193779905000,
      "total_liabilities": 11478211000
    }
  },
  "industry": "기초 의약 물질 제조업",
  "investment": [
    {
      "amount": "1,183,806,000",
      "changes": "1,183,806,000",
      "date": "2012-11-02"
    }
  ],
  "main_products": "EC-18(신약),원료의약품 제조,도매",
  "phone": "02-501-****",
  "years": [
    2023,
    2022
  ]
}